These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 32016462

  • 1. Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA‑374a/forkhead box O1 signaling axis.
    Sun Y, Peng YB, Ye LL, Ma LX, Zou MY, Cheng ZG.
    Mol Med Rep; 2020 Mar; 21(3):1471-1480. PubMed ID: 32016462
    [Abstract] [Full Text] [Related]

  • 2. Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2.
    Xu L, Zhang B, Li W.
    Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33576437
    [Abstract] [Full Text] [Related]

  • 3. Propofol suppresses cell viability, cell cycle progression and motility and induces cell apoptosis of ovarian cancer cells through suppressing MEK/ERK signaling via targeting circVPS13C/miR-145 axis.
    Lu H, Zheng G, Gao X, Chen C, Zhou M, Zhang L.
    J Ovarian Res; 2021 Feb 09; 14(1):30. PubMed ID: 33563314
    [Abstract] [Full Text] [Related]

  • 4. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
    Ma S, Tan W, Du B, Liu W, Li W, Che D, Zhang G.
    Mol Med Rep; 2016 Apr 09; 13(4):3342-8. PubMed ID: 26935490
    [Abstract] [Full Text] [Related]

  • 5. Roflumilast enhances cisplatin-sensitivity and reverses cisplatin-resistance of ovarian cancer cells via cAMP/PKA/CREB-FtMt signalling axis.
    Gong S, Chen Y, Meng F, Zhang Y, Li C, Zhang G, Huan W, Wu F.
    Cell Prolif; 2018 Oct 09; 51(5):e12474. PubMed ID: 30069985
    [Abstract] [Full Text] [Related]

  • 6. MiR-1/GOLPH3/Foxo1 Signaling Pathway Regulates Proliferation of Bladder Cancer.
    Liu MK, Ma T, Yu Y, Suo Y, Li K, Song SC, Zhang W.
    Technol Cancer Res Treat; 2019 Oct 09; 18():1533033819886897. PubMed ID: 31714185
    [Abstract] [Full Text] [Related]

  • 7. miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1/ATG14 pathway.
    Hu Z, Cai M, Zhang Y, Tao L, Guo R.
    Cell Cycle; 2020 Jan 09; 19(2):193-206. PubMed ID: 31885310
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S, Jiao JW, Sun KX, Zong ZH, Zhao Y.
    Drug Des Devel Ther; 2015 Jan 09; 9():5225-35. PubMed ID: 26396496
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Protein tyrosine phosphatase receptor type Z1 inhibits the cisplatin resistance of ovarian cancer by regulating PI3K/AKT/mTOR signal pathway.
    Wang P, Hu Y, Qu P, Zhao Y, Liu J, Zhao J, Kong B.
    Bioengineered; 2022 Jan 09; 13(1):1931-1941. PubMed ID: 35001804
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA miR-30a inhibits cisplatin resistance in ovarian cancer cells through autophagy.
    Cai Y, An B, Yao D, Zhou H, Zhu J.
    Bioengineered; 2021 Dec 09; 12(2):10713-10722. PubMed ID: 34747309
    [Abstract] [Full Text] [Related]

  • 13. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H, Wei W, Sun Y, Gao J, Wang Q, Zheng J.
    DNA Cell Biol; 2015 Jan 09; 34(1):55-62. PubMed ID: 25211326
    [Abstract] [Full Text] [Related]

  • 14. Scutellarein induces apoptosis and inhibits proliferation, migration, and invasion in ovarian cancer via inhibition of EZH2/FOXO1 signaling.
    Lang X, Chen Z, Yang X, Yan Q, Xu M, Liu W, He Q, Zhang Y, Cheng W, Zhao W.
    J Biochem Mol Toxicol; 2021 Oct 09; 35(10):e22870. PubMed ID: 34350670
    [Abstract] [Full Text] [Related]

  • 15. MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells.
    Rao YM, Shi HR, Ji M, Chen CH.
    J Huazhong Univ Sci Technolog Med Sci; 2013 Aug 09; 33(4):567-572. PubMed ID: 23904379
    [Abstract] [Full Text] [Related]

  • 16. MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells.
    Li N, Yang L, Wang H, Yi T, Jia X, Chen C, Xu P.
    PLoS One; 2015 Aug 09; 10(6):e0128886. PubMed ID: 26043084
    [Abstract] [Full Text] [Related]

  • 17. Insulin in combination with cisplatin induces the apoptosis of ovarian cancer cells via p53 and JNK activation.
    Zhao T, Bai J, Zou Q, Chen F, Xie Y.
    Mol Med Rep; 2017 Dec 09; 16(6):9095-9101. PubMed ID: 29039558
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway.
    Zhang N, Qiu J, Zheng T, Zhang X, Hua K, Zhang Y.
    Oncol Rep; 2018 Mar 09; 39(3):1034-1042. PubMed ID: 29286125
    [Abstract] [Full Text] [Related]

  • 20. Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells.
    Zhang R, Shi H, Ren F, Li X, Zhang M, Feng W, Jia Y.
    Oncol Rep; 2016 Apr 09; 35(4):2466-72. PubMed ID: 26794135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.